Objective:
To discuss the updated evidence and practical tips for the use of selective laser trabeculoplasty (SLT) in glaucoma management.
Key Findings:
- SLT is effective as a first-line treatment for early glaucoma.
- The median duration before needing repeat SLT is greater than 6 years.
- SLT can be repeated safely and effectively, with potential for annual 'booster' treatments.
Interpretation:
The findings suggest a shift in glaucoma management practices, emphasizing early intervention with SLT and its long-term benefits.
Limitations:
- Further research is needed to establish optimal protocols for SLT repetition.
- Current evidence is based on specific trials, which may not encompass all patient populations.
Conclusion:
SLT represents a promising approach in glaucoma management, with evidence supporting its early use and repeatability.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.